8-K current report · filed Jul 22, 2026

CME Group (CME) 8-K Current Report: July 22, 2026

Item EX-99.1Item 2.02CME overview

Short answer

CME Group (CME) filed an 8-K current report with the SEC on July 22, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Q2 2026 results for quarter ended June 30, 2026, announced July 22, 2026.

CME Group 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q2 2026 results for quarter ended June 30, 2026, announced July 22, 2026
  • Exhibit 99.1 contains CME’s GAAP financial results and management commentary
  • Non-GAAP revenue, expenses, operating income, net income and EPS included for comparability
  • Investors should prioritize GAAP results, using reconciled non-GAAP figures as supplemental measures

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue $1.7B and net income $1.0B; adjusted EPS $2.99 versus $2.96 in Q2 2025
  • ADV 29.8M contracts, third-highest quarterly level, while clearing and transaction fees reached $1.4B
  • Market data revenue rose 20% to record $238M, strengthening recurring, higher-margin revenue diversification
  • $95B in daily margin efficiencies supports client retention and CME’s competitive clearing proposition
  • Returned capital through $468M dividends and $695M share repurchases; cash $2.3B versus debt $3.4B at June 30, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other CME Group 8-K filings

Get the next CME 8-K as it lands

Follow CME for push alerts, or ask the research agent what this filing means.